Medicare AdvantageCoverageMedium impact
Q4 2023 Provider Newsletter
Molina Healthcare·Endocrinology, Family Medicine, Internal Medicine +1 more·Provider Newsletter
Effective date
Jan 1, 2024
We identified it
Jun 19, 2026
Summary
Molina Medicare is removing NovoLog (insulin aspart) from their formulary for 2024, replacing it with two preferred alternatives: Fiasp (insulin aspart) and ADMELOG (insulin lispro). Providers can begin transitioning patients starting December 2023.
Action Required
By December 2023: Providers should begin transitioning Medicare patients from NovoLog to preferred alternatives Fiasp or ADMELOG. Update prescribing protocols to reflect timing differences - Fiasp is given at meal start or within 20 minutes after (vs NovoLog 5-10 minutes before meals), and ADMELOG within 15 minutes before or immediately after meals. Contact Molina Medicare pharmacy at (800) 665-3086 with questions.